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Abstract
Cerebellar abnormalities are encountered in a high number of neurological diseases that present in the neonatal
period. These disorders can be categorized broadly as inherited (e.g. malformations, inborn errors of metabolism) or
acquired (e.g. hemorrhages, infections, stroke). In some disorders such as Dandy-Walker malformation or Joubert
syndrome, the main abnormalities are located within the cerebellum and brainstem. In other disorders such as
Krabbe disease or sulfite oxidase deficiency, the main abnormalities are found within the supratentorial brain, but
the cerebellar involvement may be helpful for diagnostic purposes. In In this article, we review neurological
disorders with onset in the neonatal period and cerebellar involvement with a focus on how characterization of
cerebellar involvement can facilitate accurate diagnosis and improved accuracy of neuro-functional prognosis.
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Background
In the last decade, remarkable progress has been made
in neonatal neurology. The translation of this new in-
formation from the bench to the clinic has allowed
for significant improvements in the diagnosis and
treatment of neurological disorders of preterm and
term neonates. At present, as many as 25 % of new-
borns in tertiary-level intensive care nurseries have
primary neurological conditions and many more are
at risk of neurologic injury [1].
The cerebellum accounts for only about 10 % of the
brain volume, but contains approximately 50 billion neu-
rons (more than 50 % of all the neurons of the brain)
and 200 million input fibers. The cerebellum is highly
connected with the cerebral hemispheres through numer-
ous complex anatomical and functional cerebro-cerebellar
circuits [2, 3]. The cerebro-cerebellar connections include
the motor cortex and the supplementary motor area, the
posterior and inferior parietal cortex, the superior tem-
poral cortex, the prefrontal cortex, as well as the cingulate
gyrus and the parahippocampal gyrus. The circuits of the
cerebro-cerebellar connections are the likely structural
basis for the important role of the cerebellum in motor
and neurocognitive functions. In the last decades, under-
standing of cerebellar dysfunction has evolved from pure
motor syndromes (impairments of gait, extremity coordin-
ation, speech, and ocular motor control) to more complex
neurocognitive and neurobehavioral abnormalities that
are collectively known as the “cerebellar cognitive affective
syndrome” [4].
This review article focuses on disorders with cerebellar
involvement that present during the neonatal period.
Brainstem involvement has also been included because
brainstem abnormalities often accompany cerebellar
anomalies and cerebellar and brainstem embryological
development is closely related. The diseases listed in this
article have been selected from our clinical experience,
consultation of textbooks on cerebellar disorders, neo-
natal neurology, neonatology, and neuroimaging, and a
search of Pubmed with appropriate key words. The
disorders have been broadly classified as inherited or
acquired (Table 1). Selected cerebellar and brainstem
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malformations such as rhombencephalosynapsis, the
majority of cases of Dandy-Walker malformation, and
pontine tegmental cap dysplasia have been classified as
hereditary disorders although the genetic background is
still unknown. Their origin is most likely hereditary
(genetic), not acquired based on the neuroimaging find-
ings and suggested patho-mechanisms.
The discussion of each disorder will emphasize how
understanding of cerebellar involvement may facilitate
diagnosis, elucidate pathogenesis, and affect long-term
Table 1 Neonatal neurology diseases with clinical or neuroimaging cerebellar involvement
Group of diseases Diseases Diagnostic test
Inherited Malformation Dandy-Walker malformation Brain MRI findings
Joubert syndrome Brain MRI findings
Rhombencephalosynapsis Brain MRI findings
Pontocerebellar hypoplasias Brain MRI findings, genetic analysis
Congenital muscular dystrophy due to
α-dystroglycanopathy
Muscle biopsy, genetic analysis
Brainstem disconnection Brain MRI findings
Pontine tegmental cap dysplasia Brain MRI findings
Chiari type II malformation Brain MRI findings
Neurometabolic Congenital disorders of glycosylation Transferrin electrophoresis, genetic analysis
Smith-Lemli-Opitz syndrome Elevated 7-dehydrocholesterol, genetic analysis
Non-ketotic hyperglycinemia Elevated CSF glycine concentration and CSF-to-plasma
glycine ratio, genetic analysis
Maple syrup urine disease Elevated branched-chain amino acids and branched-chain
keto-acids in blood and urine
Pyruvate dehydrogenase deficiency Abnormal enzyme function, genetic analysis
Sulfite oxidase deficiency Elevated sulfite, thiosulfate, taurine, and S-sulfocysteine
concentrations in urine, genetic analysis
Neurodegenerative Krabbe disease Low galactocerebrosidase activity in peripheral leukocytes,
genetic analysis
Cockayne syndrome Genetic analysis
Pelizaeus-Merzbacher disease Genetic analysis
Aicardi-Goutières syndrome Genetic analysis
Congenital neuronal ceroid lipofuscinosis Genetic analysis
Spinocerebellar ataxias SCA type 2 Genetic analysis
SCA type 7 Genetic analysis
Acquired Vascular Cerebellar hemorrhage Brain MRI findings
Sinovenous thrombosis Brain MRI findings
cerebellar ischemic stroke Brain MRI findings
Disrupted development of the cerebellum in preterms History of prematurity, brain MRI findings
Hypoxic-ischemic injury Brain MRI findings
Infection Congenital cytomegalovirus Viral culture, PCR, or serology within the first weeks of life,
later PCR for CMV DNA in dried blood of neonatal screening
Herpes simplex CSF viral culture or PCR
Toxic Glucocorticoids Brain MRI findings, history of glucocorticoids therapy
Teratogens Alcohol History, brain MRI findings
Retinoic acid History, brain MRI findings
Misoprostol History, brain MRI findings
Tumors Teratoma Histology
Medulloblastoma Histology
CMV cytomegalovirus, CSF cerebrospinal fluid, DNA deoxyribonucleic acid, MRI magnetic resonance imaging, PCR polymerase chain reaction
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neurocognitive and behavioral outcomes of the affected
preterm and term neonates. In addition, we provide
checklists for selected clinical (Table 2) and neuroimag-
ing (Table 3) findings. These checklists should facilitate
making the correct diagnosis or narrow the differential
diagnoses of neonatal neurological diseases with cerebel-
lar involvement. These lists can be used as “memo-lists”
and are not meant to be complete. Note that for a given
condition a range of findings may occur and not all
mentioned clinical and imaging findings have to be
present.
Inherited cerebellar lesions
Cerebellar malformations
Dandy-Walker malformation (DWM)
DWM is the most common posterior fossa malformation.
It mainly occurs sporadically and has a low recurrence risk.
DWM may be isolated or part of chromosomal anomalies
or Mendelian disorders. Recent genetic studies sug-
gested that DWM may be caused by signaling de-
fects affecting the cerebellum and its overlying
mesenchyme.
The dominant clinical feature of DWM is the occur-
rence of hydrocephalus, that typically develops during
infancy [5]. Because of the progress and increasing avail-
ability of prenatal MRI, an increasing number of cases
are being diagnosed in utero and during the neonatal
period even in the absence of hydrocephalus. Neonates
with syndromic DWM such as those with Ritscher-
Schinzel syndrome or Ellis-van Creveld syndrome may
present due to associated extracerebellar or systemic
abnormalities.
DWM is defined by neuroimaging findings including
hypoplasia, elevation, and anticlockwise rotation of the
vermis and cystic dilatation of the fourth ventricle. The
dilated fourth ventricle extends posteriorly filling nearly
Table 2 Neonatal symptoms and clinical findings that may facilitate the diagnosis of neonatal disorders with cerebellar involvement
Symptom/clinical finding Diseases
Alopecia RES
Breathing abnormalities BD, CII, cerebellar hemorrhage, CNCL, JS, NKH, PCH 1/4, PDH
Contractures CMD, CS, PCH 4
Corneal insensitivity PTCD, RES
Dysmorphic features CDG, CS, JS, RES, SLO, SOD
Dysphagia BD, CII, CMD, PCH 1/2/6, PTCD
Dystonia MSUD, PCH 2
Eye involvement (cataract, coloboma, retinitis, …) CMD, CMV, CNCL, CS, JS
Facial palsy BD, PTCD
Head titubation JS
Hyporeflexia CDG, PCH 1
Irritability Cerebellar hemorrhage, Krabbe, sinovenous thrombosis
Kidney involvement JS, SLO
Macrocephaly Cerebellar hemorrhage, CII, DWM, RES, sinovenous thrombosis, tumor
Microcephaly CMV, CNCL, PCH (mainly type 6), PDH, SLO
Nystagmus PMD
Ophthalmoplegia MSUD
Polydactyly JS
Ptosis SLO
Seizures BD, cerebellar hemorrhage and stroke, CMD, CMV, CNCL, HII, HSV, MSUD, NKH,
preterm disruption, PCH 6, PDH, SOD
Skeletal abnormalities BD, PTCD, SLO
Stridor CII, PMD
Unstable body temperature BD
Weakness CMD, PCH 1
BD brainstem disconnection, CDG congenital disorders of glycosylation, CII Chiari type II malformation, CMD congenital muscular dystrophy, CMV cytomegalovirus
infection, CNCL congenital neuronal ceroid lipofuscinosis, CS Cockayne syndrome, DWM Dandy-Walker malformation, HII hypoxic-ischemic injury, HSV herpes
simpex infection, JS Joubert syndrome, MSUD maple syrup urine disease, NKH, nonketotic hyperglycinemia, PCH pontocerebellar hypoplasia, PDH pyruvate
dehydrogenase deficiency, PMD Pelizaeus-Merzbacher disease, PTCD pontine tegmental cap dysplasia, RES rhombencephalosynapsis, SLO Smith-Lemli-Opitz
syndrome, SOD sulfite oxidase deficiency
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the entire posterior fossa [6]. Elevation of tentorium and
torcula, enlargement of the posterior fossa, hydroceph-
alus, brainstem hypoplasia, and supratentorial malforma-
tions may be present.
Correction of hydrocephalus is the main treatment in
DWM. Shunt placement within the lateral ventricles
and/or posterior fossa cyst is currently considered the
surgical treatment of choice. The long-term outcome is
variable. Abnormal vermian lobulation and additional
brain malformations are unfavorable predictors of cogni-
tive outcome [7].
DWM is defined by the cerebellar involvement. While
cerebellar involvement is unlikely to be responsible for
the neonatal presentation, it plays an important role in
clinical symptoms/findings later in life, including ataxia
(present in 30–40 % patients with DWM) and cognitive
dysfunction.
Joubert syndrome (JS)
JS has an estimated prevalence of 1:80,000, is almost
always inherited with an autosomal-recessive pattern,
and is caused by mutations in more than 30 genes
coding for proteins of the primary cilia [8, 9].
JS may present during the neonatal period [10]. Hypo-
tonia of variable severity is present in almost all patients.
An abnormal breathing pattern including tachypnea (up
to 200 breaths per minute) intermixed with apnea oc-
curs in approximately 30 % of patients. This respiratory
instability improves over time, and disappears spontan-
eously within the first 2 years of life. Recently, we
reported that head titubation is a benign, early presenta-
tion of JS [11]. Head titubation is horizontal, presents
within the first 2 months of life only when children are
awake, and decreases in severity over time until it spon-
taneously resolves. A variety of craniofacial dysmorphic
Table 3 Neuroimaging findings that may facilitate the diagnosis of neonatal disorders with cerebellar involvement
Neuroimaging finding Diseases
Calcifications AGS, CMV, CS
Callosal agenesis/dysgenesis CII, CMD, NKH, SLO
Cerebellar atrophy (global) AGS, CDG, CNCL, CS
Cerebellar cysts CMD, PCH1/2/6
Cerebellar hemispheres Atrophy Preterm disruption, PCH
Dysplasia CMD
Hypoplasia DWM, PCH
Cerebral atrophy AGS, CNCL, CS
Dentate nuclei T2-hyperintense signal Krabbe
Global cerebellar hypoplasia BD, CDG, CMV, NKH, SOD, SLO
Global cerebral edema SOD, HII
Malformation of cortical development CMD, CMV, JS
Molar tooth sign JS
Pontine hypoplasia CII, CDG, CMD, preterm disruption, JS, PCH, PTCD
Posterior fossa Small CII
Enlarged DWM
Tectal abnormality CII, CMD, JS, RES
Vermis Agenesis RES, Teratogens
Atrophy Preterm disruption, PCH
Dysplasia CMD, JS
Hypoplasia DWM, JS, PCH, PTCD
Ventriculomegaly Cerebellar hemorrhage, CII, CMD, CMV, DWM, RES, SLO,
sinovenous thrombosis, tumor
White matter signal abnormality Cerebellar AGS, CS, Krabbe, MSUD, NKH, PDH, PMD
Cerebral AGS, CMV, CMD, CS, Krabbe, MSUDa, NKHa, PMD
aonly myelinated white matter tracts, AGS Aicardi-Goutières syndrome, BD brainstem disconnection, CDG congenital disorders of glycosylation, CII, Chiari type II
malformation, CMD congenital muscular dystrophy, CMV cytomegalovirus infection, CNCL congenital neuronal ceroid lipofuscinosis, CS Cockayne syndrome, DWM
Dandy-Walker malformation, HII hypoxic-ischemic injury, HSV herpes simpex infection, JS Joubert syndrome, MSUD maple syrup urine disease, NKH nonketotic
hyperglycinemia, PCH pontocerebellar hypoplasia, PDH pyruvate dehydrogenase deficiency, PMD Pelizaeus-Merzbacher disease, PTCD pontine tegmental cap
dysplasia, RES rhombencephalosynapsis, SLO Smith-Lemli-Opitz syndrome, SOD sulfite oxidase deficiency
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features may also be present in JS including prominent
forehead, high rounded eyebrows, epicanthal folds, and
open mouth. Systemic abnormalities including colobo-
mas, retinal dystrophy, renal cysts, and polydactyly are
also found during the neonatal period. The presence of
enoral findings (e.g. tongue hamartoma, additional fren-
ula, and upper lip notch) and/or mesoaxial polydactyly
allows the diagnosis of oral-facial-digital syndrome type
VI, a phenotype of JS. Ataxia, ocular motor apraxia, and
intellectual disability are common features in JS that
develop later in life.
JS is defined by the presence of the molar tooth sign
(MTS) on axial neuroimaging. The MTS is characterized
by elongated, thickened, and horizontally orientated su-
perior cerebellar peduncles and a deep interpeduncular
fossa (Fig. 1a-c). Hypoplasia and dysplasia of the cerebel-
lar vermis is another consistent finding. The spectrum
of neuroimaging findings extends beyond the MTS and
vermian hypo-dysplasia, and may include a variety of
infra- and supratentorial findings [12].
The long-term outcome of JS is variable. A small num-
ber of children may die in the neonatal period or infancy
for unknown causes (possibly related to breathing abnor-
malities). Intellectual disability is present in almost all
patients, but there is a broad spectrum of severity. Liver
and renal involvement may cause high morbidity and
mortality and needs appropriate work-up and regular
follow-up.
In JS, cerebellar involvement allows for early diagnosis
and is most likely responsible for the clinical presenta-
tion during the neonatal period.
Rhombencephalosynapsis (RES)
RES is a sporadic malformation that is most likely
caused by disruption of dorsal-ventral patterning.
Children with RES typically present later in life with
ataxia and intellectual disability [13]. RES, however, is
commonly associated with hydrocephalus due to sten-
osis of the Sylvian aqueduct and affected children may
present as newborns with congenital hydrocephalus. RES
may occur in isolation or be part of the Gómez‐López‐
Hernández syndrome, which is characterized by RES,
parietal alopecia, trigeminal anesthesia, and craniofacial
dysmorphic signs [14]. Alopecia is usually bilateral,
bitemporal, and present from birth.
RES is defined by absence of the vermis and continu-
ity/fusion of the cerebellar hemispheres, dentate nuclei,
and superior cerebellar peduncles (Fig. 1d-f ) [15]. RES
may be associated with other brain anomalies such as
hydrocephalus, tectal dysplasia, and callosal dysgenesis.
Fig. 1 a, Sagittal, b, Axial, and c, Coronal T2-weighted MR images of a 2-day-old term male newborn with Oral-Facial-Digital syndrome type VI (a
phenotype of Joubert syndrome) show severe hypoplasia of the cerebellar vermis and both cerebellar hemispheres, the characteristic molar tooth
sign including thickened and elongated superior cerebellar peduncles and a deepened interpeduncular fossa, and a hypothalamic hamartoma
(arrows)(reprinted with permission from Poretti A et al., AJNR Am J Neuroradiol, 2008;29:1090–91). d, Sagittal, e, Axial, and f, Coronal T2-weighted
MR images of a 5-day-old term male neonate with rhombencephalosynapsis reveal continuity of the cerebellar hemispheres, dentate nuclei, and
superior cerebellar peduncles without a midline intervening vermis. On the sagittal image, no primary fissure is seen. In addition, dysplasia of
the tectal plate, obstruction of the Sylvian aqueduct at the level of the inferior colliculi, and marked supratentorial hydrocephalus. Note that
the dentate nucleus is visible on a midsagittal image, while in normal anatomy the vermis separates the dentate nuclei in the midline
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The long-term cognitive outcome is variable ranging
from normal cognitive function to severe intellectual
disability. Severe RES with associated tectal dysplasia
and other cerebral anomalies is a predictor of poor cog-
nitive outcome.
In RES, cerebellar involvement allows the diagnosis.
However, it is not likely to be responsible for the neo-
natal presentation, but may plays a role in clinical symp-
toms/findings later in life (ataxia) and impaired
cognition.
Pontocerebellar hypoplasias (PCHs)
PCHs are a group of autosomal recessive neurodegen-
erative disorders with a prenatal onset [16]. To date,
10 subtypes with different phenotypes and genotypes
have been identified. Some forms of PCH present
during the neonatal period [16]. PCH1 is character-
ized by loss of motor neurons in the anterior horn of
the spinal cord resulting in severe hypotonia, weak-
ness, dysphagia, and respiratory insufficiency [17]. In
PCH2, neonatal presentation includes impairment of
swallowing, jitteriness, and dystonia [17]. PCH4 has a
severe neonatal course with hypertonia, congenital
contractures, and primary hypoventilation requiring
prolonged mechanical ventilation [18]. PCH6 is char-
acterized by neonatal encephalopathy with dysphagia,
seizures, generalized hypotonia, and progressive
microcephaly [19]. Developmental milestones are not
reached. Lactic acidemia and elevated lactate in the
cerebrospinal fluid have been found in patients with
PCH6 due to reduced activity of mitochondrial com-
plexes I, III, and IV.
The cerebellar abnormality in PCH is characterized by
ponto-cerebellar hypoplasia and progressive atrophy
with prenatal onset [20]. In some cases of PCH (particu-
larly type 2 due to TSEN54 mutations) there is more
severe involvement of the cerebellar hemispheres com-
pared to the vermis. On coronal T2-weighted images,
this pattern has a “dragonfly” appearance that is created
by flattened cerebellar hemispheres (the “wings”) and a
relatively preserved cerebellar vermis (the “body”). Ab-
sence or significant reduction of the pontine prominence
is characteristic of prenatal onset in PCH. In PCH4, the
cerebellar vermis is more severely affected compared to
the hemispheres.
The long-term outcome is variable and depends on
the underlying type of PCH. In PCH, the cerebellar and
brainstem involvement may suggest the diagnosis that
subsequently needs to be confirmed by genetic analysis.
It is unclear how the cerebellar involvement may explain
the clinical features, however brainstem involvement
may be partially responsible for the movement disorders
reported in PCH.
Congenital muscular dystrophies due to α-
dystroglycanopathy
The α-dystroglycanopathies are a group of autosomal-
recessive congenital muscular dystrophies resulting from
mutations in more than 15 genes responsible for the O-
glycosylation of α-dystroglycan [21]. The muscles, brain,
and eyes are usually affected. Based on the severity of
findings, various phenotypes have been described includ-
ing Fukuyama disease, muscle-eye-brain disease, and
Walker-Warburg syndrome, which is the most severe
form [22]. Neonatal presentation is typical and includes
weakness with predominant involvement of the proximal
muscles, hypotonia, contractures, seizures, and macro-
cephaly [23]. Eye involvement is variable and may in-
clude retinal dysplasia and dystrophy, glaucoma,
microophthalmia, and cataracts. Typically, creatine kin-
ase is markedly elevated.
On neuroimaging, neonatal infratentorial involvement
is characterized by cerebellar hypo-dysplasia, pontine hy-
poplasia, ventral pontine cleft, and ponto-mesencephalic
kinking. Multiple small cortical/subcortical cerebellar
cysts are common in muscle-eye-brain disease and Fu-
kuyama disease, but develop only in the first months of
life [24]. Supratentorial involvement is variable and
ranges from mild ventriculomegaly, diffuse periventricu-
lar white matter changes, and focal areas of polymicro-
gyria to severe hydrocephalus, generalized white matter
signal changes, and diffuse cortical abnormalities, in-
cluding cobblestone lissencephaly [22].
The long-term outcome is variable and depends on
the underlying phenotype (e.g. Fukuyama disease has the
most favorable outcome) and genotype.
In α-dystroglycanopathies, the cerebellar and brain-
stem involvement associated with the cerebral anomalies
and clinical findings may suggest the diagnosis that then
needs to be confirmed by genetic analysis or muscle bi-
opsy. The clinical presentation is most likely explained
by the cerebral, muscle, and eye involvement, while the
role of the cerebellar involvement in the clinical presen-
tation remains unclear.
Pontine tegmental cap dysplasia (PTCD)
PTCD is a rare sporadic brainstem malformation with
unknown genotype and no familial recurrence and most
likely results from abnormal axonal guidance and/or
neuronal migration.
Children with PTCD may present in the neonatal
period with hearing loss, facial paralysis, trigeminal
anesthesia, dysphagia, and reduced opening of the
mouth [25, 26]. Systemic involvement with vertebral
segmentation anomalies, rib malformations, and con-
genital heart defects has been observed.
The neuroimaging findings are pathognomonic and
include a flattened ventral pons, vaulted pontine
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tegmentum (the “cap”), partial absence of the middle
cerebellar peduncles, absence of the inferior cerebellar
peduncles, vermian hypoplasia, a molar tooth-like aspect
of the ponto-mesencephalic junction, and absent inferior
olivary prominence [25]. The degree of brainstem dys-
plasia seems to correlate with the developmental
disability.
The intellectual prognosis appears to be highly vari-
able, ranging between mild cognitive delay to severe
disability.
In PTCD, the brainstem involvement is diagnostic and
responsible for the clinical presentation.
Brainstem disconnection (BD)
BD is an extremely rare abnormality of unknown eti-
ology. All children are symptomatic at birth. The clinical
manifestations are characterized by brainstem dysfunc-
tion including absent or weak sucking and swallowing,
absent or markedly insufficient breathing in the majority
of patients, increased or decreased muscle tone, and re-
duced or poor visual fixation [27]. Seizures and unstable
body temperature may occur.
BD is defined by the characteristic neuroimaging pat-
tern including nearly complete absence of a brainstem
segment with the intact rostral and caudal portions con-
nected only by a thin cord of tissue on neuroimaging
[27]. BD is usually associated with cerebellar hypoplasia.
Supratentorial abnormalities are unusual. In the majority
of the patients, the basilar artery is missing.
The majority of children die within the first 2 months
of life. Nasogastric tube or gastrostomy, intubation and
mechanical ventilation, and temperature management
systems are needed to treat the swallowing disorders, re-
spiratory insufficiency, and episodic hyperthermia these
infants have.
In BD, the brainstem involvement is diagnostic and re-
sponsible for the clinical presentation.
Chiari type II malformation (CII)
CII is not a cerebellar malformation, but a spinal dys-
raphism with secondary morphological anomalies of the
posterior fossa contents. Nevertheless, we decided to in-
clude CII in this group of diseases. CII occurs in about 1
of 1000 live births and is universally associated with non
skin-covered myelomeningocele/spinal dysraphia [28].
Affected neonates are symptomatic during the neo-
natal period due to spinal involvement and hydroceph-
alus. Clinical features of CII related to cerebellar and
brainstem anomalies, are present in approximately 30 %
of neonates, and include dysphagia, vocal cord paralysis
with laryngeal stridor, and central or obstructive ventila-
tion abnormalities with apneic episodes. The presence of
stridor, apnea, cyanotic spells, and dysphagia is associ-
ated with increased mortality [29].
CII is defined by a small posterior fossa with inferior
displacement of the lower cerebellum, medulla, and
fourth ventricle through the foramen magnum [28].
Hydrocephalus is present in up to 90 % of affected neo-
nates and is caused by the hindbrain malformation that
blocks/impairs the cerebrospinal fluid hydro-dynamics
of the posterior fossa or by aqueductal stenosis. Add-
itional morphological abnormalities include beaking of
the tectal plate, pontine hypoplasia, callosal dysgenesis,
large massa intermedia, and cortical malformations [30].
Intrauterine surgical repair of the myelomeningocele
between 19 and 25 weeks of gestation has been shown
to reduce the rate of shunt placement, improve motor
function at 30 months, and decrease severity of hind-
brain herniation [31, 32].
In CII, the cerebellar and brainstem findings are diagnos-
tic and partially responsible for the clinical presentation.
Neurometabolic disorders with neonatal cerebellar
involvement
Congenital disorders of glycosylation (CDG)
CDG include nearly 50 inborn errors of glycan metabol-
ism with an estimated prevalence of 1:20,000 [33]. This
rapidly growing group of disorders encompasses defects
in N-glycosylation, O-glycosylation, and lipid-linked gly-
cosylation. The most common congenital disorder of
glycosylation is phosphomannomutase II deficiency
(PMM2-CDG) [33].
In these diseases, there is significant phenotypic diver-
sity. Classically babies present with multi-system in-
volvement including abnormal fat distribution, inverted
nipples, hypotonia, hyporeflexia, and strabismus [33].
Ataxia may develop in some patients. In PMM2-CDG,
brain MRI may be normal, however, MRI often reveals
significant pontocerebellar hypoplasia and superimposed
cerebellar atrophy and T2-hyperintense signal of the cere-
bellar cortex [34]. Cerebellar atrophy and T2-hyperintense
signal of the cerebellar cortex are typically not present in
the neonatal period, but may develop later.
In CDG, pontocerebellar hypoplasia may suggest the
diagnosis, which must then be confirmed by transferrin
electrophoresis and genetic analysis. Pontocerebellar hy-
poplasia may explain the occurrence of ataxia in CDG.
Treatment for most CDG remains symptomatic and pal-
liative. The prognosis of CDG is variable and depends
on the underlying phenotype and genotype.
Smith-Lemli-Opitz syndrome (SLO)
SLO has an estimated prevalence of around 1:20,000–
40,000 births and results from abnormal cholesterol
biosynthesis [35]. Patients typically have dysmorphic
features, which can include a broad nasal bridge, ante-
verted nares, and long philtrum. Skeletal abnormalities
are common and most patients have syndactyly of the
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2nd and 3rd toes. A variety of systems can be involved
and neonates can have cardiovascular, gastrointestinal,
renal, and genitourinary abnormalities. Neurologic
manifestations include congenital microcephaly, ptosis,
and hypotonia [35]. Structural brain abnormalities are
seen in about one-third of patients and include ventri-
culomegaly, hypoplastic frontal lobes, absent or hypo-
plastic corpus callosum, and, in some patients,
cerebellar hypoplasia [36].
The diagnosis of SLO is based on the detection of ele-
vated 7-dehydrocholesterol in blood or tissues and can
be confirmed by mutation analysis. The blood choles-
terol level is not a reliable screening test. Management is
symptomatic. Long-term outcome is variable and de-
pends on the severity of the disease and associated mal-
formations. Cardiovascular and brain malformations
may be lethal.
Cerebellar involvement with global cerebellar hypopla-
sia is inconsistently present and non-specific.
Nonketotic hyperglycinemia (NKH)
NKH has an estimated prevalence of around 1:55,000–
65,000 births and results from a deficiency in glycine
cleavage with subsequent toxic systemic accumulation of
glycine. Central nervous system toxicity results and in-
fants typically present in the first 2 days of life with
depressed alertness, hypotonia, myoclonic jerks, and re-
fractory seizures. Many progress quickly to apnea, coma,
and death [37]. EEG commonly reveals a burst suppres-
sion pattern. Early neuroimaging findings include re-
stricted diffusion of myelinated white matter tracks
(including cerebellar and brainstem white matter tracts),
agenesis of the corpus callosum, and a glycine peak on
1H-MR-spectroscopy [36]. Hypoplasia of the cerebellar
vermis is seen in a minority of patients [37].
The diagnosis is established by an increase in CSF gly-
cine concentration and an increased CSF-to-plasma
glycine ratio, and can be confirmed by genetic analysis.
Sodium benzoate may be used to reduce plasma gly-
cine levels. Otherwise management is primarily symp-
tomatic. Long-term outcome is usually poor and early
death may occur due to apnea.
Cerebellar involvement with vermis hypoplasia is in-
consistently present and non-specific. 1H-MR-spectros-
copy showing a glycine peak may facilitate the diagnosis
of NKH.
Maple syrup urine disease (MSUD)
MSUD is an autosomal recessive condition that results
from a deficiency in branched-chain α-ketoacid dehydro-
genase enzyme and causes an accumulation of leucine,
isoleucine, and valine. Leucine and its byproducts exert
the primary neurotoxic effects resulting in intramyelinic
edema. MSUD has an estimated prevalence of 1:150,000
live births.
Neonates typically present in the first week of life with
poor feeding, recurrent emesis, lethargy, fluctuating oph-
thalmoplegia, and seizures [38]. Many newborns develop
dystonia and stereotyped, “bicycling” or “fencing” move-
ments of the extremities [38]. During the acute phase of
deterioration, neuroimaging shows T2-hyperintense sig-
nal and decreased diffusion of the cerebellar and other
white matter regions that are already myelinated (Fig. 2)
[36, 39].
The diagnosis is confirmed by detecting increased
values of branched-chain amino acids (leucine, isoleu-
cine, and valine) and branched-chain keto-acids in blood
and urine. Early diagnosis is paramount for a favorable
long-term outcome; children may be able to achieve a
normal cognitive outcome if appropriate intervention
(diet) occurs early in the neonatal course [40].
In MSUD, cerebellar involvement on neuroimaging is
distinctive and may be helpful in establishing an early
diagnosis.
Pyruvate dehydrogenase deficiency (PDH)
PDH results from mutations in the pyruvate dehydro-
genase complex, which is responsible for the conversion
of pyruvate to acetyl-CoA. In the neonatal form, patients
typically present with hypotonia, encephalopathy, micro-
cephaly, and tachypnea [41]. Approximately one-third
develop seizures. MRI findings include dysgenesis of the
corpus callosum, mega cisterna magna, heterotopias,
pachygyria and cortical atrophy. T2-hyperintense signal
and decreased diffusion can occur in the cerebellar white
matter, posterior limb of the internal capsule, and occipi-
tal lobes. 1H-MR-spectroscopy may reveal a doublet
peak at 1.3 ppm compatible with lactate [36].
Lactate is typically elevated in the blood and CSF. The
diagnosis is suspected by abnormal enzyme function and
can be confirmed by genetic analysis. Treatment typic-
ally includes cofactor supplementation (e.g. thiamine
and carnitine) and ketogenic diet. Long-term outcome is
generally poor.
Cerebellar involvement with T2-hyperintense signal
and restricted diffusion in the cerebellar white matter is
non-specific.
Sulfite oxidase deficiency (SOD)
Isolated SOD and SOD due to molybdenum cofactor
deficiency result in the accumulation of sulfites, which
are toxic to the developing brain [42]. SOD may
present with poor feeding, emesis and seizures [43].
The onset of seizures is typically accompanied by
rapid neurologic deterioration [44]. Dysmorphic fea-
tures are present in up to 75 % of patients, including
coarse facies, small nose, elongated face, and long
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philtrum [42, 43]. Ectopia lentis is present later in the
disease course [43]. Initial neuroimaging with MRI
reveals generalized white matter edema, mimicking
hypoxic ischemic injury [36].
The diagnosis is based on high sulfite, thiosulfate, S-
sulfocysteine, and taurine concentrations in urine and
should be confirmed by genetic analysis. The long-term
outcome is usually poor including intractable seizures
and death in early infancy. Substitution therapy with
purified cyclic pyranopterin monophosphate is a new,
promising causative therapy for molybdenum cofactor
deficiency [45].
Cerebellar involvement with global cerebellar hypopla-
sia is inconsistently present and non-specific [36].
Neurodegenerative disorders with neonatal cerebellar
involvement
Krabbe disease (KD)
KD has an estimated prevalence of 1:100,000 and is
caused by deficiency of the lysosomal enzyme
Fig. 2 a-c, Axial T2-weighted MR images of a 20-day-old male term neonate with maple syrup urine disease show swelling and hyperintense
signal of the cerebellar white matter, dorsal pons, corticospinal tracts along its course in the basis pontis, midbrain, and posterior limbs of the
internal capsule, and thalami. d-f, Trace of diffusion images and g-i, Apparent diffusion coefficient (ADC) maps of the same newborn reveal
bright DWI-signal and matching low ADC values, respectively, in the cerebellar white matter, dorsal pons, corticospinal tracts in the basis
pontis, midbrain, and posterior limb of the internal capsule, and thalami representing restricted diffusion/cytotoxic edema compatible with
extensive ongoing injury to the myelinated parts of the brain
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galactocerebrosidase and is characterized by failure of
myelination in the central and peripheral nervous sys-
tems [46]. Neonatal presentation of KD is characterized
by spasticity, marked irritability, and lack of motor de-
velopment [47]. Neuroimaging shows signal abnormal-
ities of the lateral thalami, corona radiata, cerebellar
white matter, and dentate nuclei.
In KD, cerebellar involvement is characteristic and
may suggest the diagnosis, which needs to be confirmed
by low galactocerebrosidase activity in peripheral leuko-
cytes and genetic analysis. Treatment is symptomatic.
Long-term prognosis is poor and neurodegeneration and
early death occurs within the first 2–3 years of life.
Cockayne syndrome (CS)
CS is a nucleotide excision repair disease with an esti-
mated prevalence of 1:200,000. CS may present during
the neonatal period (CS type II) with prenatal and post-
natal growth failure, congenital cataracts, loss of adipose
tissue, joint contractures, and distinctive face with small,
deep-set eyes and prominent nasal bridge [48]. Myelin-
ation is disturbed within the central and peripheral
nervous system. Additional brain involvement includes
basal ganglia calcifications and severe cerebral and cere-
bellar atrophy.
In CS type II, cerebellar atrophy is a non-specific find-
ing. The entire clinical and imaging findings may suggest
the diagnosis that needs confirmation by genetic analysis.
Management is supportive and the progressive course
leads typically to death before the end of the first decade.
Pelizaeus-Merzbacher disease (PMD)
PMD is a hypomyelinating disorder that is caused by
PLP1 mutations and has an estimated prevalence of
1:400,000 [49]. PMD may present during the neonatal
period (connatal PMD) with hypotonia, inspiratory
stridor, horizontal or rotatory nystagmus, and seizures.
Neuroimaging shows near complete absence of central
nervous system myelin including brainstem and cerebel-
lar white matter tracts (Fig. 3).
In PMD, complete absence of myelin within the brain-
stem and cerebellar white matter associated with the
clinical findings may suggest the diagnosis, which then
needs to be confirmed by genetic analysis. Management
is symptomatic. PMD has a progressive course leading
to death by the second decade.
Aicardi-Goutières syndrome (AGS)
AGS is a genetically heterogeneous inflammatory disease
and is an important diagnostic consideration in neonates
with imaging findings suggestive of perinatal infection.
AGS is consistently associated with an interferon signa-
ture, which is sustained over time and can be used for
diagnostic purposes. Newborns with AGS classically
have intracranial calcifications, white matter abnormal-
ities, and cerebral atrophy. Calcifications can be seen in
the dentate nuclei in approximately 30 % of affected
children [50]. In addition, cerebellar atrophy has been
reported inconsistently as a late feature.
In AGS, dentate nuclei calcifications as well as other
neuroimaging findings and clinical features may suggest
the diagnosis that needs confirmation by genetic ana-
lysis. Treatment is symptomatic and the majority of pa-
tients presenting early in life die within the first 10 years
of life.
Congenital neuronal ceroid lipofuscinosis (CNCL)
CNCL is a rare neurodegenerative disease caused by
mutations in the Cathepsin D gene [51]. The neonatal
presentation is severe and includes therapy-resistant sei-
zures, respiratory insufficiency, and marked microceph-
aly. Neuroimaging findings are characterized by severe
cerebral and cerebellar atrophy. Absence of electro-
retinographic responses and iso-electric electroencephal-
ography are characteristic.
Fig. 3 a-c, Axial T2-weighted MR images of a 5-day-old male term neonate with genetically confirmed Pelizaeus-Merzbacher disease presenting with
marked muscular hypotonia, rotatory nystagmus, and inspiratory stridor show a homogeneous increased hyperintense signal of the supra- and infraten-
torial white matter including the corticospinal tracts within the posterior limb of the internal capsule bilaterally compatible with hypomyelination
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In CNCL, severe neonatal cerebellar atrophy associ-
ated with the above imaging and clinical findings may
suggest the diagnosis that then needs to be confirmed by
genetic analysis. The neonatal clinical features are most
likely caused by severe cerebral atrophy. Failure of
neurological development and development of a vegeta-
tive state are usually followed by death within the first
weeks of life.
Spinocerebellar ataxias (SCAs) with neonatal cerebellar
involvement
SCAs are a clinically heterogeneous group of disorders
with a global prevalence of 1–4/100.000 [52]. More than
40 different types of SCAs have been described and they
are inherited with an autosomal-dominant pattern [53].
Various SCAs types are so called trinucleotide repeat
disorders that are mostly caused by expansions of CAG
repeats. SCAs typically present in adults and are rare
causes of childhood ataxia. In rare cases, SCA2 and
SCA7 may present in the neonatal period.
SCA2 is caused by an expansion of a CAG trinucleo-
tide repeat near the 5′ coding region of the ataxin 2
gene on chromosome 12q24. There is an inverse correl-
ation between the repeat size and the age of onset: full
penetrance alleles are usually 37–39 in adult cases, while
very large expansions of over 200 have been reported in
infants [54]. The neonatal presentation of SCA2 is char-
acterized by hypotonia, absent reflexes, dysphagia, poor
head control, and lack of visual fixation [55, 56]. In the
first year of life, infants with SCA2 usually develop
developmental delay or regression, progressive enceph-
alopathy, optic atrophy, retinitis pigmentosa, and sei-
zures [54–56]. Neuroimaging findings typically include
cerebellar atrophy, mild reduction in size of the pons,
and progressive volume loss of the cerebral white mat-
ter with secondary ventriculomegaly and thinning of
the corpus callosum, but brain MRI may reveal normal
findings [54].
SCA7 is caused by expansion of a CAG trinucleotide
repeat in the first coding exon of the ataxin 7 gene lo-
cated on chromosome 3p. There is an inverse correl-
ation between the size of the repeat and age of onset.
The adult and childhood phenotype is characterized by
visual loss due to retinitis pigmentosa, progressive
ataxia, dysmetria, intention tremor, dysarthria, dyspha-
gia, and brisk reflexes. The neonatal phenotype is quite
different and includes failure to thrive, weight loss, weak-
ness, hypotonia, and acquired microcephaly [57, 58]. Pa-
tients may have a patent ductus arteriosus and evidence of
multiple organ failure. In the first year of age, infant
with SCA7 may develop neurological deterioration and
retinal dystrophy. Neuroimaging findings are character-
ized by cerebellar and cerebral atrophy with secondary
ventriculomegaly.
Acquired cerebellar lesions
Disruption of cerebellar development in preterms
Cerebellar injuries in premature infants may be grouped
into two categories: 1) primarily destructive injuries in-
cluding hemorrhage and ischemia (as discussed later)
and 2) injuries primarily impairing cerebellar develop-
ment [59]. The latter may represent the most common
type of cerebellar abnormality of the premature infant.
Two pathomechanisms are possible: 1) direct effects on
the rapidly growing/developing cerebellum and 2) re-
mote effects through altered trophic trans-synaptic
interactions.
Direct effects on the growing cerebellum may include
hypoxic-ischemic injury or toxic effect of glucocorticoids
(as discussed later), blood products, and undernutrition.
In preterm neonates with intraventricular hemorrhages,
hemosiderin deposition on the cerebellar surface and a
progressive reduction in size of cerebellum (particularly
the cerebellar hemispheres) and pons may occur [60].
Hemosiderin is likely toxic for the granule precursor
cells of the external granular layer and their impaired
survival and/or proliferation may cause cerebellar under-
development [59].
Remote trans-synaptic effects that primarily affect
neuronal connections between cerebrum and cerebellum
may lead to cerebellar underdevelopment in preterm ne-
onates [61]. Disruption of cerebellar development in pre-
term neonates is frequently associated with contralateral
periventricular leukomalacia (PVL) and other cerebral
lesions raising the possibility that cerebellar underdevel-
opment may be secondary to the loss of supratentorial
white matter. Unilateral cerebral brain injuries are asso-
ciated with significantly decreased volume of the contra-
lateral cerebellar hemisphere. Conversely, unilateral
cerebellar injuries are associated with significantly de-
creased volume in specific regions of the contralateral
cerebral hemisphere (dorsolateral prefrontal, premotor,
sensorimotor, and midtemporal gray and white matter)
[62]. In addition, infants with bilateral diffuse PVL typic-
ally have symmetric bilateral decreases in cerebellar
volume.
In the neonatal period, the cerebellar abnormality is
most often clinically silent, making this group of disor-
ders difficult to diagnose. Symptoms and signs related to
the direct effect of intraventricular hemorrhage or a re-
mote cerebral injury may provide clues to the provider.
Examples include seizure, bulging fontanelle, alteration
of consciousness, or focal neurologic deficit.
On conventional MRI, following morphologic patterns
of disrupted cerebellar development may be seen: 1)
symmetric volume reduction of the cerebellar hemi-
spheres and a small vermis with preserved shape
(Fig. 4c-d), 2) symmetric reduction in hemispheric vol-
ume with an enlarged, balloon-shaped fourth ventricle
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and a small, deformed vermis, and 3) normal overall
cerebellar shape with extensive reduction of its dimen-
sions [60]. Pontine hypoplasia is consistently seen. In
addition, unilateral cerebellar hypoplasia may be seen
secondary to contralateral PVL.
In ex-preterm neonates with cerebellar underdevelop-
ment, impairments in motor, cognitive, and behavioral
(socialization difficulties, early autistic features) func-
tions are highly prevalent [63, 64]. Cerebellar volume
has been shown to predict motor and cognitive perform-
ance in ex-preterm adolescents [64].
Vascular disorders of the neonatal cerebellum
Cerebellar hemorrhages
Cerebellar hemorrhages are common neonatal acquired
cerebellar injuries, particularly in preterm neonates. The
prevalence depends on the degree of prematurity and
birth weight. In a large series of cases, the prevalence of
cerebellar hemorrhages was 2.7 % in preterm neonates
with a birth weight above 750 g and 8.7 % in those below
750 g [65].
Cerebellar hemorrhages typically originate from the
cerebellar germinal matrix within the external granular
layer that is thickest at 24 weeks of gestation and begins
to involute at 30 weeks [66]. Therefore, 21 through
27 weeks gestation is the most vulnerable time period
for cerebellar hemorrhages. Less commonly, hemor-
rhages may originate in the residual germinal matrix of
the ventricular zone in the roof of the fourth ventricle
and primarily involve the vermis.
The pathogenesis of cerebellar hemorrhages is multi-
factorial. Different risk factors have been reported for
the preterm and term neonates. In preterm neonates,
maternal, intrapartum, and early postnatal characteristics
are known risk factors. These include assisted concep-
tion, abnormal fetal heart rate, C-section delivery, lower
Apgar scores, need for pressor support and high
frequency ventilation, presence of a persistent ductus
arteriosus, low pH, low plasma bicarbonate, low plate-
lets, and low hematocrit values [65, 67]. In term neo-
nates cerebellar hemorrhages are primarily associated
with traumatic delivery [68].
Fig. 4 a, Ultrasonography image through the mastoid fontanel of a 14-day-old neonate born at 26 weeks of gestation show a cerebellar hemorrhage
(arrows). b, Coronal T2-weighted image at 2 months of life reveals encephalomalacic changes within the right cerebellar hemisphere with T2-
hypointense foci representing deposition of blood products. c, Sagittal T1- and d, Coronal T2-weighted MR images of a 3-year-old boy born at 25 weeks
gestation reveal a small posterior fossa, marked reduction in the size of the cerebellar hemispheres, which have a skeletonized appearance and
appear more affected compared to the small vermis. Together with the pontine hypoplasia, constellation of findings suggest disruption of the
cerebellar development as a sequela of prematurity. In addition, a T2-hypointense signal is noted in the left cerebellar folia suggesting hemosiderin
deposition due to remote hemorrhage. Finally, a thinned corpus callosum and encephalomalacic changes in the supratentorial brain are also seen
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Large cerebellar hemorrhages (>1 cm) may present
with apnea, bradycardia, full fontanelle, or opisthotonus
[68]. The majority of cerebellar hemorrhages are clinic-
ally silent in the neonatal time period and require a high
index of suspicion to make the diagnosis [65–67].
The traditional ultrasonographic approach through the
anterior fontanelle has a low sensitivity for detecting
cerebellar hemorrhages because of the echogenic tentor-
ium and the limited penetration depth of the ultrasound
waves [65]. The advent of mastoid fontanel and subocci-
pital views significantly increased the sensitivity of
ultrasonography for detection of cerebellar hemorrhage
[65–67]. However, a high number of cerebellar hemor-
rhages remain undetected by ultrasonography com-
pared to MRI [67, 69]. Brain MRI including
susceptibility-weighted imaging (SWI) is the diagnostic
tool of choice to detect cerebellar hemorrhages
(Fig. 4a-b).
Cerebellar hemorrhages occur most commonly in only
one cerebellar hemisphere (71 %). The vermis is involved
in 20 % of patients, and associated supratentorial lesions
are found in up to 77 % of cases [65, 67]. Focal atrophy
of the affected hemisphere with a secondary reduction
in size of the pons may be seen approximately 2 months
later in as many as 37 % of patients [65]. Interestingly,
significant volume reduction of the contralateral cerebral
hemisphere may be present and most likely results from
impaired remote trans-synaptic neurodegeneration [65].
In preterm neonates, cerebellar hemorrhages result in
high mortality (14 % compared to 1 % of control pre-
terms) and long-term neurological morbidity (66 % com-
pared to 5 % of control preterms) [65, 70]. Neurological
sequelae include motor dysfunction in 48 % (hypotonia
in 100 %, abnormal gait in 37 %, and ocular motor
abnormalities in 23 %), expressive and receptive lan-
guage dysfunction in 37 % to 42 %, and neurocognitive
dysfunction in 40 % of children [70]. Additionally,
autistic features may become apparent in up to 42 %,
and more than 30 % have internalizing behavioral prob-
lems. Lesions within the cerebellar hemispheres have
been associated with impaired cognitive function, while
injury of the cerebellar vermis may cause motor, lan-
guage, and behavioral/social problems. In term neonates,
the neurological sequelae are similar, but less prevalent
than in preterms [68].
Sinovenous thrombosis with cerebellar involvement
Cerebral sinovenous thrombosis (CSVT) affects 2.6–12/
100,000 neonates and is defined by thrombosis within
the superficial or deep venous system [71]. In neonates,
39 % of CSVT involve the transverse sinuses, and 30 %
involve the straight sinus [72]. In these cases, thrombosis
may lead to venous congestion and secondary venous
infarction of the hemispheric white matter with or with-
out hemorrhagic conversion of the ischemic cerebellum.
Generally, many risk factors for neonatal CSVT have
been reported [72–74]. However, no specific risk factors
have been reported for CSVT affecting the posterior
fossa. Clinically, CSVT tends to present with seizure or
decreased alertness rather than a focal neurologic sign.
The presentation may be subtle and some neonates may
have isolated irritability [72]. No specific symptoms have
been reported for CSVT affecting the cerebellum. A high
index of suspicion is required to make the diagnosis.
Brain MRI with MR venography is the neuroimaging
modality of choice [73]. In addition, diffusion weighted
imaging (DWI) and SWI may be helpful to identify is-
chemic and/or hemorrhagic complications. DWI may also
be helpful to directly visualize the intravascular thrombus.
A hypercoagulability evaluation should be performed to
identify risk factors for future thromboses. Treatment is
controversial and varies by institution; there are studies
that indicate that anticoagulation may be safe, and may
decrease the risk of clot propagation [74].
Overall the outcome of CSVT is variable: 45–64 % of
the affected neonates have a normal outcome, 3–19 %
die, 16–18 % have seizures (higher risk with thalamic in-
jury), and 33–65 % have neurologic deficits including
both motor and cognitive deficits [72, 73]. No specific
outcomes have been reported for neonates with CSVT
affecting the cerebellum.
Cerebellar ischemic stroke
In neonates, cerebellar ischemic stroke is very rare and
less common than cerebellar hemorrhages [68]. Some
hypothesize that neonatal ischemic stroke is responsible
for damage involving mostly the inferior parts of the
cerebellum with secondary pontine hypoplasia in very
preterm neonates [75, 76]. The consistent association of
cerebellar lesions with cerebral white matter injury may
suggest a similar pathogenesis of both lesions (e.g. global
hypoxia/ischemia or infection/inflammation rather than
vascular occlusive). Alternatively, injuries primarily impair-
ing cerebellar development (discussed above) may be to
blame.
In the neonatal period, ischemic cerebellar stroke is
most often clinically silent, but apnea and seizures may
occur. Brain MRI with DWI is the diagnostic neuroim-
aging modality of choice.
Hypoxic-ischemic injury (HII)
HII affects 1–3 newborns per 1000 full-term births in
the United States [77]. Depending on the severity and
timing of injury, four neuroimaging patterns involving
cerebral cortex/white matter, usually in a parasagittal
distribution, deep nuclear structures, especially putamen
and thalamus, and brainstem tegmentum have been
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reported [77]. Though literature about cerebellar in-
volvement in HII is scant, animal models have shown
that Purkinje cells are highly vulnerable to HII due to
their inability to generate energy during hypoxia [78].
The relative immaturity of the neonatal Purkinje cells in
the cerebellar cortex is thought to have a protective ef-
fect on the cerebellar gray matter in HII [79].
In children with HII and cerebellar involvement, clin-
ical cerebellar signs have not been reported. This is not
surprising, given neonates with cerebellar involvement
typically have extensive supratentorial injuries [80]. In
these patients, the clinical presentation is dominated by
features such as seizures and encephalopathy that result
from supratentorial injury.
In neonatal HII, acute injury of the cerebellum is
rarely depicted on conventional MRI sequences (3–4 %
of the patients), but common on neuropathology exam
of the brains of asphyxiated newborns who died (up to
70–80 %) [80]. This difference suggests that cerebellar
involvement is most likely present in neonates with se-
vere HII. Alternatively, cerebellar injury may be subtle
and difficult to identify on conventional MRI sequences.
The application of diffusion tensor imaging (DTI)
showed reduced factional anisotropy and increased ap-
parent diffusion coefficient values in the cerebellar pe-
duncles of asphyxiated neonates [80]. Interestingly, all
neonates who had changes in DTI scalars in the cerebel-
lar tracts also had injury to the supratentorial brain. This
supports the idea that cerebellar injury in HII occurs
predominantly in severely asphyxiated neonates with
cerebral injury. The association between supratentorial
(particularly basal ganglia and thalami) and cerebellar
abnormalities in HII has also been shown on follow-up
MRI studies [81, 82]. Involvement of both 1) basal gan-
glia and thalami and 2) cerebellum raises the possibility
that cerebellar injury in HII may be secondary to trans-
synaptic degeneration via the thalamo-cerebellar path-
way [81]. On follow-up studies in HII, selective
involvement of the anterior part of the cerebellar vermis
is seen as a hyperintense signal on T2-weighted images
and/or selective atrophy [81, 82]. In addition, minimal
subsequent growth of the cerebellar vermis has been
shown in infants with HII and severe basal ganglia and
thalamic lesions [83]. Vermian involvement may serve as
an independent predictor of severe HII associated with
significant neurologic disability [83].
Infectious etiologies with neonatal cerebellar involvement
Isolated cerebellar involvement in fetal and neonatal in-
fection is rare. While cytomegalovirus infection classic-
ally results in periventricular calcifications, a number of
additional brain abnormalities can be seen, including
cerebellar hypoplasia (Fig. 5) [84]. The presence of cere-
bellar hypoplasia suggests an early (first trimester)
transmission of cytomegalovirus, which interferes with
early brain development. Recently, Oosterom et al.
showed that severe structural abnormalities including
cerebellar hypoplasia are associated with poor neurode-
velopmental outcome and/or sensorineural hearing loss
[85]. It is unclear, however, how much cerebellar hypo-
plasia may contribute to poor neurodevelopmental out-
come compared to other structural abnormalities such
as polymicrogyria.
Imaging findings in neonatal herpes simplex virus
(HSV) encephalitis are variable. Imaging often reveals
multifocal areas of diffusion restriction (cytotoxic
edema); however, cases of isolated brainstem and cere-
bellum involvement have been described in HSV-2 [86].
Extrinsic neurotoxic agents with neonatal cerebellar
involvement
The neonatal cerebellum has been shown to have the
highest number of glucocorticoid receptors in the brain
[87]. Antenatally, glucocorticoids are often given to has-
ten lung maturation. Postnatally, glucocorticoids may be
administered for prolonged hypotension and broncho-
pulmonary dysplasia. Multiple animal models have dem-
onstrated that glucocorticoids delay the growth of the
cerebellum in distinct species [88]. Preterm studies have
demonstrated similar findings in humans, with one
group reporting a 20 % reduction in cerebellar volume
in patients receiving dexamethasone, as compared to
control subjects [89]. In one series of 172 serially imaged
premature infants, postnatal betamethasone and hydro-
cortisone were associated with decreased cerebellar vol-
umes of 10 % and 8 %, respectively. In the same cohort,
antenatal betamethasone treatment was not associated
with a change in cerebellar volume [90]. A smaller cere-
bellar volume does not seem to affect the clinical pres-
entation of the affected premature infants. Follow-up
studies at school age are needed to detect the long-term
motor and cognitive consequences of a smaller cerebel-
lar volume due to postnatal betamethasone and hydro-
cortisone administration.
Congenital cerebellar tumors
Congenital brain tumors are rare and represent only
0.5–1.5 % of all pediatric brain tumors [91]. Teratomas
are the most frequent congenital brain tumors, while
non-teratomatous neoplasms including choroid plexus
papilloma, medulloblastoma, and craniopharyngioma are
less common. Up to 70 % of the tumors originate within
the supratentorial brain, while the remaining 30 % are
located in the posterior fossa. Macrocrania is the most
common presentation; the open sutures and cartilagin-
ous character of the fetal/neonatal skull allow significant
expansion in utero. Hydrocephalus, intratumoral
hemorrhage, heart failure and hydrops resulting from
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high-cardiac output, and polyhydramnios are less com-
mon presentations. The diagnosis of a cerebellar tumor
is made by a combination of conventional and advanced
neuroimaging, and histological exam is needed to
characterize the exact tumor type and histology. Progno-
sis in neonates is generally poor, but depends on the
histological type, extension of the tumor, and involve-
ment of adjacent structures.
Conclusion
As illustrated in this review, the cerebellum is involved
in a broad range of pathologies seen in the newborn
period. In many cases, characterization of cerebellar in-
volvement can facilitate diagnosis, guide management,
and improve the ability to provide an accurate prognosis
for the infant. While the cerebellum is a relatively small
structure anatomically, it plays a critical role in overall
neurodevelopment.
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